Prostate cancer
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1.Patients who declined active surveillance and opted for radical prostatectomy at our institution; 2.Patients who underwent transperineal saturated prostate biopsy at our hospital prior to radical prostatectomy; 3.Histopathological confirmation of PCa with a maximum biopsy Gleason score of 3+3; 4.No evidence of metastasis based on preoperative computed tomography (CT) or magnetic resonance imaging(MRI); 5. No prior administration of anti-androgenic treatment (ADT) or chemotherapy
Exclusion criteria
Exclusion criteria: 1. Incomplete clinical data; 2. Other pelvic floor surgeries during biopsy or radical prostatectomy; 3. Presence of other coexisting malignancies; 4.History of autoimmune or chronic inflammatory diseases; 5. Presence of acute or chronic infections prior to surgery
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| proportion of positive biopsies;Prostate specific antigen;Prostate volume;PSA density;PIRADS score; | — |
Secondary
| Measure | Time frame |
|---|---|
| surgical method;operative route; | — |
Countries
China
Contacts
Northern Jiangsu People's Hospital